Population based estimates of comorbidities affecting risk for complications from COVID-19 in the US
Mary L. Adams, David L. Katz, Joseph Grandpre
doi: https://doi.org/10.1101/2020.03.30.20043919
Mary L. Adams
1On Target Health Data LLC, Suffield, CT, USA
MS, MPHDavid L. Katz
2Yale-Griffin Prevention Research Center, Derby, CT, USA
MD, MPH, FACPM, FACP, FACLMJoseph Grandpre
3Wyoming Department of Health, Cheyenne, WY, USA
PhD, MPHArticle usage
Posted April 02, 2020.
Population based estimates of comorbidities affecting risk for complications from COVID-19 in the US
Mary L. Adams, David L. Katz, Joseph Grandpre
medRxiv 2020.03.30.20043919; doi: https://doi.org/10.1101/2020.03.30.20043919
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2840)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (802)
- Genetic and Genomic Medicine (4423)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2848)
- Health Policy (1047)
- Hematology (374)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4183)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6774)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)